Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Alexandre A. Jácome"'
Autor:
Victor Hugo Fonseca de Jesus, Maria Cecília Mathias-Machado, João Paulo Fogacci de Farias, Marcelo Porfirio Sunagua Aruquipa, Alexandre A. Jácome, Renata D’Alpino Peixoto
Publikováno v:
Cancers, Vol 15, Iss 20, p 5015 (2023)
Pancreatic ductal adenocarcinoma (PDAC) remains an important cause of cancer-related mortality, and it is expected to play an even bigger part in cancer burden in the years to come. Despite concerted efforts from scientists and physicians, patients h
Externí odkaz:
https://doaj.org/article/ba100b811f3644cea2d52da588e56ed0
Autor:
Bruno L. Ferrari, Carlos Gil Ferreira, Márcia Menezes, Pedro De Marchi, Jorge Canedo, Andréia Cristina de Melo, Alexandre A. Jácome, Tomás Reinert, Rafael Duarte Paes, Bárbara Sodré, Carlos H. Barrios, Rodrigo Dienstmann
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 46-55 (2021)
PURPOSEThe COVID-19 pandemic remains a public health emergency of global concern. Determinants of mortality in the general population are now clear, but specific data on patients with cancer remain limited, particularly in Latin America.MATERIALS AND
Externí odkaz:
https://doaj.org/article/10ad72b4b6d04a04aabd7a3b9deccbf0
Autor:
Alexandre A. Jácome, Benny Johnson
Publikováno v:
Cells, Vol 12, Iss 7, p 1068 (2023)
Despite significant advances in the surgical and systemic therapy of colorectal cancer (CRC) in recent decades, recurrence rates remain high. Apart from microsatellite instability status, the decision to offer adjuvant chemotherapy to patients with C
Externí odkaz:
https://doaj.org/article/09734c0711f64a1ab07316729a2e1104
Autor:
Maria Cecília Mathias-Machado, Renata D’Alpino Peixoto, Camila Motta Venchiarutti Moniz, Alexandre A. Jácome
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 2029 (2022)
Squamous cell carcinoma of the anal canal (SCCA) is a rare neoplasm, but with rising incidence rates in the past few decades; it is etiologically linked with the human papillomavirus (HPV) infection and is especially prevalent in immunocompromised pa
Externí odkaz:
https://doaj.org/article/88c86bdb822c49f49263f6f9eb1cc54f
Autor:
Gauri R. Varadhachary, Jonathan M. Loree, F. Anthony Greco, Xuemei Wang, Michael J. Overman, Justin Jao, Jeannelyn S. Estrella, Aurelio Matamoros, Brandon Smaglo, Jignesh Modha, Nishat P. Dhillon, Ryan W. Huey, Anneleis Willett, Eric Bhang, Alexandre A. Jácome, Hyunsoo Hwang, Kanwal Raghav
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d20c3c4a065e8e087654d5ef973b291
https://doi.org/10.1158/1078-0432.22479951.v1
https://doi.org/10.1158/1078-0432.22479951.v1
Autor:
Gauri R. Varadhachary, Jonathan M. Loree, F. Anthony Greco, Xuemei Wang, Michael J. Overman, Justin Jao, Jeannelyn S. Estrella, Aurelio Matamoros, Brandon Smaglo, Jignesh Modha, Nishat P. Dhillon, Ryan W. Huey, Anneleis Willett, Eric Bhang, Alexandre A. Jácome, Hyunsoo Hwang, Kanwal Raghav
Purpose:Prognostic uncertainty is a major challenge for cancer of unknown primary (CUP). Current models limit a meaningful patient-provider dialogue. We aimed to establish a nomogram for predicting overall survival (OS) in CUP based on robust clinico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78548ccbf7887cc2a3bdfe7e6d06690f
https://doi.org/10.1158/1078-0432.c.6530337.v1
https://doi.org/10.1158/1078-0432.c.6530337.v1
Autor:
Alexandre A. Jácome, Benny Johnson
Publikováno v:
EMJ Oncology. :43-52
Metastatic colorectal cancer (mCRC) is a markedly heterogeneous disease, which portends a poor prognosis, with an estimated 5-year overall survival rate of approximately 15%. The standard of care of systemic therapy remains fluoropyrimidine-based che
Publikováno v:
Clinical Colorectal Cancer. 20:265-272
Liver-limited metastatic colorectal cancer is a potentially curable disease. Pathologic response (pR) to preoperative chemotherapy (CT) for colorectal liver metastases (CLM) is a surrogate endpoint for overall survival (OS). We conducted the first me
Autor:
Alexandre A Jácome, Renata D’Alpino Peixoto, Mariana V Gil, Juliana Ominelli, Gabriel Prolla, Rodrigo Dienstmann, Cathy Eng
Publikováno v:
Expert opinion on biological therapy. 22(10)
Despite the use of multimodality therapy, locally advanced rectal cancer (LARC) still presents high rates of disease recurrence. Fluoropyrimidine-based chemotherapy concurrently with radiation therapy (RT) remains the cornerstone of neoadjuvant thera
Autor:
Cathy Eng, Kristen K. Ciombor, May Cho, Jennifer A. Dorth, Lakshmi N. Rajdev, David P. Horowitz, Marc J. Gollub, Alexandre A. Jácome, Natalie A. Lockney, Roberta L. Muldoon, Mary Kay Washington, Brittany A. O'Brian, Amala Benny, Cody M. Lebeck Lee, Al B. Benson, Karyn A. Goodman, Van Karlyle Morris
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(24)
The social stigma surrounding an anal cancer diagnosis has traditionally prevented open discussions about this disease. However, as recent treatment options and an increasing rate of diagnoses are made worldwide, awareness is growing. In the United S